EPCAM and prostate cancer: Following TGF-β treatment of prostate cancer LNCaP cells, they observed that the ratios of EpCAM to prostate-specific membrane antigen (PSMA) changed from 4-fold to 0.5-fold, suggesting the initiation of EMT transition.